Literature DB >> 2649027

In vivo leucocyte migration in Behçet's syndrome.

J Efthimiou1, I E Addison, B V Johnson.   

Abstract

Serial studies of leucocyte migration in vivo were carried out in 15 patients with Behçet's syndrome using a skin window technique. Where possible, patients with and without active disease were studied during and in the absence of treatment. In patients with active disease neutrophil migration was frequently greater than normal, particularly with respect to numbers of cells migrating. There was also an increased frequency of emigrating neutrophils with less or more nuclear lobes than normal. In three patients in whom function of skin window neutrophils was studied nitroblue tetrazolium reduction and phagocytosis and killing of Candida guilliermondiae were normal. The monocyte component of the skin window was more often reduced in patients than in normal controls. Corticosteroid treatment did not exert a major effect on leucocyte migration, though the doses involved were relatively small. Neutrophil abnormalities were common in patients and particularly those with active disease. These results suggest that neutrophil hyperactivity may have an important role in the pathogenesis of Behçet's syndrome.

Entities:  

Mesh:

Year:  1989        PMID: 2649027      PMCID: PMC1003722          DOI: 10.1136/ard.48.3.206

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  13 in total

Review 1.  Behçet's disease. Report of 41 cases and a review of the literature.

Authors:  T Chajek; M Fainaru
Journal:  Medicine (Baltimore)       Date:  1975-05       Impact factor: 1.889

2.  Cytochemical identification of monocytes and granulocytes.

Authors:  L T Yam; C Y Li; W H Crosby
Journal:  Am J Clin Pathol       Date:  1971-03       Impact factor: 2.493

3.  Polymorphonuclear leucocyte function in Behçet's disease.

Authors:  J D Sobel; S Haim; N Obedeanu; T Meshulam; D Merzbach
Journal:  J Clin Pathol       Date:  1977-03       Impact factor: 3.411

4.  The pathergy test and Behçet's syndrome in Britain.

Authors:  P G Davies; J N Fordham; J R Kirwan; C G Barnes; W J Dinning
Journal:  Ann Rheum Dis       Date:  1984-02       Impact factor: 19.103

5.  Polymorphonuclear function in Behçet's syndrome.

Authors:  J N Fordham; P G Davies; A Kirk; H L Currey
Journal:  Ann Rheum Dis       Date:  1982-08       Impact factor: 19.103

6.  Display and analysis of cell size distributions with a Coulter Counter interfaced to an Apple II microcomputer.

Authors:  J Wenger; J S Nowak; O Kai; R M Franklin
Journal:  J Immunol Methods       Date:  1982-11-12       Impact factor: 2.303

7.  Abnormal polymorphonuclear leucocyte chemotaxis in Behçet's syndrome.

Authors:  D W James; J R Walker; M J Smith
Journal:  Ann Rheum Dis       Date:  1979-06       Impact factor: 19.103

8.  Effect of high-dose methylprednisolone therapy on phagocyte function in systemic lupus erythematosus.

Authors:  S H Boghossian; D A Isenberg; G Wright; M L Snaith; A W Segal
Journal:  Ann Rheum Dis       Date:  1984-08       Impact factor: 19.103

9.  Pulmonary disease in Behçet's syndrome.

Authors:  J Efthimiou; C Johnston; S G Spiro; M Turner-Warwick
Journal:  Q J Med       Date:  1986-03

10.  Pathology of the lung in Behçet's disease. Case report and review of the literature.

Authors:  R E Slavin; W J de Groot
Journal:  Am J Surg Pathol       Date:  1981-12       Impact factor: 6.394

View more
  3 in total

Review 1.  Behçet's disease.

Authors:  T Inoue; K Satake
Journal:  Gastroenterol Jpn       Date:  1991-10

2.  Immunopathology of Behçet's disease.

Authors:  R J Powell; S Dunstan
Journal:  Postgrad Med J       Date:  1991-06       Impact factor: 2.401

Review 3.  Behcet's disease complicated with myelodysplastic syndrome: a report of two cases and review of the literature.

Authors:  K Yano; K Eguchi; K Migita; H Takashima; M Tamura; K Izumino; I Sasagawa; N Sadamori; S Nagataki
Journal:  Clin Rheumatol       Date:  1996-01       Impact factor: 2.980

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.